Cargando…
Highly sensitive interleukin 6 detection by employing commercially ready liposomes in an LFA format
Recent years have confirmed the ubiquitous applicability of lateral flow assays (LFA) in point-of-care testing (POCT). To make this technology available for low abundance analytes, strategies towards lower limits of detections (LOD), while maintaining the LFA’s ease of use, are still being sought. H...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590136/ https://www.ncbi.nlm.nih.gov/pubmed/34773470 http://dx.doi.org/10.1007/s00216-021-03750-5 |
_version_ | 1784598892917030912 |
---|---|
author | Rink, Simone Kaiser, Barbara Steiner, Mark-Steven Duerkop, Axel Baeumner, Antje J. |
author_facet | Rink, Simone Kaiser, Barbara Steiner, Mark-Steven Duerkop, Axel Baeumner, Antje J. |
author_sort | Rink, Simone |
collection | PubMed |
description | Recent years have confirmed the ubiquitous applicability of lateral flow assays (LFA) in point-of-care testing (POCT). To make this technology available for low abundance analytes, strategies towards lower limits of detections (LOD), while maintaining the LFA’s ease of use, are still being sought. Here, we demonstrate how liposomes can significantly improve the LOD of traditional gold nanoparticle (AuNP)–based assays while fully supporting a ready-to-use system for commercial application. We fine-tuned liposomes towards photometric and fluorescence performance on the synthesis level and applied them in an established interleukin 6 (IL-6) immunoassay normally using commercial AuNP labels. IL-6’s low abundance (< 10 pg mL(−1)) and increasing relevance as prognostic marker for infections make it an ideal model analyte. It was found that liposomes with a high encapsulant load (150 mmol L(−1) sulforhodamine B (SRB)) easily outperform AuNPs in photometric LFAs. Specifically, liposomes with 350 nm in diameter yield a lower LOD even in complex matrices such as human serum below the clinically relevant range (7 pg mL(−1)) beating AuNP by over an order of magnitude (81 pg mL(−1)). When dehydrated on the strip, liposomes maintained their signal performance for over a year even when stored at ambient temperature and indicate extraordinary stability of up to 8 years when stored as liquid. Whereas no LOD improvement was obtained by exploiting the liposomes’ fluorescence, an extraordinary gain in signal intensity was achieved upon lysis which is a promising feature for high-resolution and low-cost detection devices. Minimizing the procedural steps by inherently fluorescent liposomes, however, is not feasible. Finally, liposomes are ready for commercial applications as they are easy to mass-produce and can simply be substituted for the ubiquitously used AuNPs in the POCT market. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00216-021-03750-5. |
format | Online Article Text |
id | pubmed-8590136 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-85901362021-11-15 Highly sensitive interleukin 6 detection by employing commercially ready liposomes in an LFA format Rink, Simone Kaiser, Barbara Steiner, Mark-Steven Duerkop, Axel Baeumner, Antje J. Anal Bioanal Chem Research Paper Recent years have confirmed the ubiquitous applicability of lateral flow assays (LFA) in point-of-care testing (POCT). To make this technology available for low abundance analytes, strategies towards lower limits of detections (LOD), while maintaining the LFA’s ease of use, are still being sought. Here, we demonstrate how liposomes can significantly improve the LOD of traditional gold nanoparticle (AuNP)–based assays while fully supporting a ready-to-use system for commercial application. We fine-tuned liposomes towards photometric and fluorescence performance on the synthesis level and applied them in an established interleukin 6 (IL-6) immunoassay normally using commercial AuNP labels. IL-6’s low abundance (< 10 pg mL(−1)) and increasing relevance as prognostic marker for infections make it an ideal model analyte. It was found that liposomes with a high encapsulant load (150 mmol L(−1) sulforhodamine B (SRB)) easily outperform AuNPs in photometric LFAs. Specifically, liposomes with 350 nm in diameter yield a lower LOD even in complex matrices such as human serum below the clinically relevant range (7 pg mL(−1)) beating AuNP by over an order of magnitude (81 pg mL(−1)). When dehydrated on the strip, liposomes maintained their signal performance for over a year even when stored at ambient temperature and indicate extraordinary stability of up to 8 years when stored as liquid. Whereas no LOD improvement was obtained by exploiting the liposomes’ fluorescence, an extraordinary gain in signal intensity was achieved upon lysis which is a promising feature for high-resolution and low-cost detection devices. Minimizing the procedural steps by inherently fluorescent liposomes, however, is not feasible. Finally, liposomes are ready for commercial applications as they are easy to mass-produce and can simply be substituted for the ubiquitously used AuNPs in the POCT market. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00216-021-03750-5. Springer Berlin Heidelberg 2021-11-13 2022 /pmc/articles/PMC8590136/ /pubmed/34773470 http://dx.doi.org/10.1007/s00216-021-03750-5 Text en © The Author(s) 2021, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Paper Rink, Simone Kaiser, Barbara Steiner, Mark-Steven Duerkop, Axel Baeumner, Antje J. Highly sensitive interleukin 6 detection by employing commercially ready liposomes in an LFA format |
title | Highly sensitive interleukin 6 detection by employing commercially ready liposomes in an LFA format |
title_full | Highly sensitive interleukin 6 detection by employing commercially ready liposomes in an LFA format |
title_fullStr | Highly sensitive interleukin 6 detection by employing commercially ready liposomes in an LFA format |
title_full_unstemmed | Highly sensitive interleukin 6 detection by employing commercially ready liposomes in an LFA format |
title_short | Highly sensitive interleukin 6 detection by employing commercially ready liposomes in an LFA format |
title_sort | highly sensitive interleukin 6 detection by employing commercially ready liposomes in an lfa format |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590136/ https://www.ncbi.nlm.nih.gov/pubmed/34773470 http://dx.doi.org/10.1007/s00216-021-03750-5 |
work_keys_str_mv | AT rinksimone highlysensitiveinterleukin6detectionbyemployingcommerciallyreadyliposomesinanlfaformat AT kaiserbarbara highlysensitiveinterleukin6detectionbyemployingcommerciallyreadyliposomesinanlfaformat AT steinermarksteven highlysensitiveinterleukin6detectionbyemployingcommerciallyreadyliposomesinanlfaformat AT duerkopaxel highlysensitiveinterleukin6detectionbyemployingcommerciallyreadyliposomesinanlfaformat AT baeumnerantjej highlysensitiveinterleukin6detectionbyemployingcommerciallyreadyliposomesinanlfaformat |